Welcome to LookChem.com Sign In|Join Free

CAS

  • or

893566-37-5

N-(5-chloro-4-methylpyridin-2-yl)pivalamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

893566-37-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 893566-37-5 Structure

  • Basic information

    1. Product Name: N-(5-chloro-4-methylpyridin-2-yl)pivalamide
    2. Synonyms:
    3. CAS NO:893566-37-5
    4. Molecular Formula:
    5. Molecular Weight: 226.706
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 893566-37-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-(5-chloro-4-methylpyridin-2-yl)pivalamide(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-(5-chloro-4-methylpyridin-2-yl)pivalamide(893566-37-5)
    11. EPA Substance Registry System: N-(5-chloro-4-methylpyridin-2-yl)pivalamide(893566-37-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 893566-37-5(Hazardous Substances Data)

893566-37-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 893566-37-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,5,6 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 893566-37:
(8*8)+(7*9)+(6*3)+(5*5)+(4*6)+(3*6)+(2*3)+(1*7)=225
225 % 10 = 5
So 893566-37-5 is a valid CAS Registry Number.

893566-37-5Relevant articles and documents

Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections

Magee, Thomas V.,Ripp, Sharon L.,Li, Bryan,Buzon, Richard A.,Chupak, Lou,Dougherty, Thomas J.,Finegan, Steven M.,Girard, Dennis,Hagen, Anne E.,Falcone, Michael J.,Farley, Kathleen A.,Granskog, Karl,Hardink, Joel R.,Huband, Michael D.,Kamicker, Barbara J.,Kaneko, Takushi,Knickerbocker, Michael J.,Liras, Jennifer L.,Marra, Andrea,Medina, Ivy,Nguyen, Thuy-Trinh,Noe, Mark C.,Obach, R. Scott,O'Donnell, John P.,Penzien, Joseph B.,Reilly, Usa Datta,Schafer, John R.,Shen, Yue,Stone, Gregory G.,Strelevitz, Timothy J.,Sun, Jianmin,Tait-Kamradt, Amelia,Vaz, Alfin D. N.,Whipple, David A.,Widlicka, Daniel W.,Wishka, Donn G.,Wolkowski, Joanna P.,Flanagan, Mark E.

experimental part, p. 7446 - 7457 (2010/06/13)

Respiratory tract bacterial strains are becoming increasingly resistant to currently marketed macrolide antibiotics. The current alternative telithromycin (1) from the newer ketolide class of macrolides addresses resistance but is hampered by serious safe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 893566-37-5